肌少症与抑郁症之间关系的研究进展
收稿日期: 2021-04-12
网络出版日期: 2022-07-25
基金资助
上海市科学技术委员会科研计划项目(18411964500);上海市科学技术委员会科研计划项目(20ZR1435100);上海市老龄化和妇儿健康研究专项(2020YJZX0122)
高磊, 高艳虹 . 肌少症与抑郁症之间关系的研究进展[J]. 内科理论与实践, 2021 , 16(06) : 442 -446 . DOI: 10.16138/j.1673-6087.2021.06.016
| [1] | Tournadre A, Vial G, Capel F, et al. Sarcopenia[J]. Joint Bone Spine, 2019, 86(3): 309-314. |
| [2] | World Health Organization. Depression and other common mental disorders[EB/OL]. 2017. http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf. |
| [3] | 中华医学会骨质疏松和骨矿盐疾病分会. 肌少症共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(3): 215-227. |
| [4] | Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019, 6(3): 211-224. |
| [5] | Casey DA. Depression in older adults: a treatable medical condition[J]. Prim Care, 2017, 44(3): 499-510. |
| [6] | 荣健, 戈艳红, 孟娜娜, 等. 2010-2019年中国老年人抑郁症患病率的Meta分析[J]. 中国循证医学杂志, 2020, 20(1): 26-31. |
| [7] | Yanagita M, Willcox BJ, Masaki KH, et al. Disability and depression: investigating a complex relation using physical performance measures[J]. Am J Geriatr Psychiatry, 2006, 14(12): 1060-1068. |
| [8] | Kim NH, Kim HS, Eun CR, et al. Depression is associated with sarcopenia, not central obesity, in elderly korean men[J]. J Am Geriatr Soc, 2011, 59(11): 2062-2068. |
| [9] | Brooks JM, Titus AJ, Bruce ML, et al. Depression and handgrip strength among U.S. adults aged 60 years and older from NHANES 2011-2014[J]. J Nutr Health Aging, 2018, 22(8): 938-943. |
| [10] | Hsu YH, Liang CK, Chou MY, et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study[J]. Geriatr Gerontol Int, 2014, 14 Suppl 1: 102-108. |
| [11] | Demakakos P, Cooper R, Hamer M, et al. The bidirectional association between depressive symptoms and gait speed: evidence from the English Longitudinal Study of Ageing (ELSA)[J]. PLoS One, 2013, 8(7): e68632. |
| [12] | Fukumori N, Yamamoto Y, Takegami M, et al. Association between hand-grip strength and depressive symptoms: Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS)[J]. Age Ageing, 2015, 44(4): 592-598. |
| [13] | Ishii S, Chang C, Tanaka T, et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults[J]. PLoS One, 2016, 11(9): e0162898. |
| [14] | Chen X, Guo J, Han P, et al. Twelve-month incidence of depressive symptoms in suburb-dwelling Chinese older adults: role of sarcopenia[J]. J Am Med Dir Assoc, 2019, 20(1): 64-69. |
| [15] | Chang KV, Hsu TH, Wu WT, et al. Is sarcopenia associated with depression?[J]. Age Ageing, 2017, 46(5): 738-746. |
| [16] | Byeon CH, Kang KY, Kang SH, et al. Sarcopenia is not associated with depression in Korean adults: results from the 2010-2011 Korean National Health and Nutrition Examination Survey[J]. Korean J Fam Med, 2016, 37(1): 37-43. |
| [17] | Nascimento CM, Ingles M, Salvador-Pascual A, et al. Sarcopenia, frailty and their prevention by exercise[J]. Free Radic Biol Med, 2019, 132: 42-49. |
| [18] | Hallgren M, Herring MP, Owen N, et al. Exercise, physical activity, and sedentary behavior in the treatment of depression: broadening the scientific perspectives and clinical opportunities[J]. Front Psychiatry, 2016, 7: 36. |
| [19] | Park SS, Seo YK, Kwon KS. Sarcopenia targeting with autophagy mechanism by exercise[J]. BMB Rep, 2019, 52(1): 64-69. |
| [20] | Xia Z, Cholewa J, Zhao Y, et al. Targeting inflammation and downstream protein metabolism in sarcopenia[J]. Front Physiol, 2017, 8: 434. |
| [21] | Hughes MM, Connor TJ, Harkin A. Stress-related immune markers in depression: implications for treatment[J]. Int J Neuropsychopharmacol, 2016, 19(6): pyw001. |
| [22] | Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia[J]. Front Physiol, 2017, 8: 1045. |
| [23] | Yoo SZ, No MH, Heo JW, et al. Role of exercise in age-related sarcopenia[J]. J Exerc Rehabil, 2018, 14(4): 551-558. |
| [24] | Meng SJ, Yu LJ. Oxidative stress, molecular inflammation and sarcopenia[J]. Int J Mol Sci, 2010, 11(4): 1509-1526. |
| [25] | 黄晓幸. 免疫炎症反应在抑郁症中作用的研究进展[J]. 微循环学杂志, 2020, 30(4): 78-81. |
| [26] | Remelli F, Vitali A, Zurlo A, et al. Vitamin D deficiency and sarcopenia in older persons[J]. Nutrients, 2019, 11(12): 2861. |
| [27] | Geng C, Shaikh AS, Han W, et al. Vitamin D and depression: mechanisms, determination and application[J]. Asia Pac J Clin Nutr, 2019, 28(4): 689-694. |
| [28] | Abiri B, Vafa M. Vitamin D and muscle sarcopenia in aging[J]. Methods Mol Biol, 2020, 2138: 29-47. |
| [29] | Moretti R, Morelli ME, Caruso P. Vitamin D in neurological diseases[J]. Int J Mol Sci, 2018, 19(8): 2245. |
| [30] | Pertile RA, Cui X, Eyles DW. Vitamin D signaling and the differentiation of developing dopamine systems[J]. Neuroscience, 2016, 333: 193-203. |
| [31] | Huiberts LM, Smolders KCHJ. Effects of vitamin D on mood and sleep in the healthy population: interpretations from the serotonergic pathway[J]. Sleep Med Rev, 2021, 55: 101379. |
| [32] | Zhang WY, Guo YJ, Wang KY, et al. Neuroprotective effects of vitamin D and 17β-estradiol against ovariectomy-induced neuroinflammation and depressive-like state[J]. Int Immunopharmacol, 2020, 86: 106734. |
| [33] | Dupont J, Dedeyne L, Dalle S, et al. The role of omega-3 in the prevention and treatment of sarcopenia[J]. Aging Clin Exp Res, 2019, 31(6): 825-836. |
| [34] | Deacon G, Kettle C, Hayes D, et al. Omega 3 polyunsaturated fatty acids and the treatment of depression[J]. Crit Rev Food Sci Nutr, 2017, 57(1): 212-223. |
| [35] | Wei Y, Meng Y, Li N, et al. The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis[J]. Food Funct, 2021, 12(1): 30-40. |
| [36] | van Dronkelaar C, van Velzen A, Abdelrazek M, et al. Minerals and sarcopenia; the role of calcium, iron, magnesium, phosphorus, potassium, selenium, sodium, and zinc on muscle mass, muscle strength, and physical performance in older adults[J]. J Am Med Dir Assoc, 2018, 19(1): 6-11. |
| [37] | Wang J, Um P, Dickerman BA, et al. Zinc, magnesium, selenium and depression: a review of the evidence, potential mechanisms and implications[J]. Nutrients, 2018, 10(5): 584. |
| [38] | Ikeda K, Horie-Inoue K, Inoue S. Functions of estrogen and estrogen receptor signaling on skeletal muscle[J]. J Steroid Biochem Mol Biol, 2019, 191: 105375. |
| [39] | Albert KM, Newhouse PA. Estrogen, stress, and depression: cognitive and biological interactions[J]. Annu Rev Clin Psychol, 2019, 15: 399-423. |
| [40] | Georgakis MK, Thomopoulos TP, Diamantaras AA, et al. Association of age at menopause and duration of reproductive period with depression after menopause[J]. JAMA Psychiatry, 2016, 73(2): 139-149. |
| [41] | MacNeil LG, Baker SK, Stevic I, et al. 17β-estradiol attenuates exercise-induced neutrophil infiltration in men[J]. Am J Physiol Regul Integr Comp Physiol, 2011, 300(6): R1443-R1451. |
| [42] | Yamada Y, Tada M, Mandai K, et al. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study[J]. Clin Rheumatol, 2020, 39(6): 1757-1764. |
| [43] | Hong N, Lee J, Ku CR, et al. Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism[J]. Clin Endocrinol (Oxf), 2019, 90(2): 267-276. |
| [44] | Dean J, Keshavan M. The neurobiology of depression[J]. Asian J Psychiatr, 2017, 27: 101-111. |
| [45] | Shah OJ, Kimball SR, Jefferson LS. Acute attenuation of translation initiation and protein synthesis by glucocorticoids in skeletal muscle[J]. Am J Physiol Endocrinol Metab, 2000, 278(1): E76-E82. |
| [46] | Martín AI, Priego T, López-Calderón A. Hormones and muscle atrophy[J]. Adv Exp Med Biol, 2018, 1088: 207-233. |
| [47] | Cid-Díaz T, Santos-Zas I, González-Sánchez J, et al. Obestatin controls the ubiquitin-proteasome and auto-phagy-lysosome systems in glucocorticoid-induced muscle cell atrophy[J]. J Cachexia Sarcopenia Muscle, 2017, 8(6): 974-990. |
| [48] | Lützner N, Kalbacher H, Krones-Herzig A, et al. FOXO 3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop[J]. PLoS One, 2012, 7(7): e42166. |
| [49] | Dwyer JB, Aftab A, Radhakrishnan R, et al. Hormonal treatments for major depressive disorder: state of the art[J]. Am J Psychiatry, 2020, 177(8): 686-705. |
| [50] | Bloise FF, Oliveira TS, Cordeiro A, et al. Thyroid hormones play role in sarcopenia and myopathies[J]. Front Physiol, 2018, 9: 560. |
| [51] | 倪敏, 吴琪. 甲状腺激素与抑郁症相关性分析[J]. 中国现代医生, 2020, 58(10): 15-18. |
| [52] | Milanesi A, Lee JW, Yang A, et al. Thyroid hormone receptor alpha is essential to maintain the satellite cell niche during skeletal muscle injury and sarcopenia of aging[J]. Thyroid, 2017, 27(10): 1316-1322. |
| [53] | Larsson L, Müller U, Li X, et al. Thyroid hormone regulation of myosin heavy chain isoform composition in young and old rats, with special reference to ⅡⅩ myosin[J]. Acta Physiol Scand, 1995, 153(2): 109-116. |
| [54] | Pak K, Kim M, Kim K, et al. Cerebral glucose metabolism and cerebral blood flow in thyroid dysfunction[J]. Sci Rep, 2020, 10(1): 1335. |
| [55] | Fukao A, Takamatsu J, Arishima T, et al. Graves’ disease and mental disorders[J]. J Clin Transl Endocrinol, 2020, 19: 100207. |
| [56] | 张音, 沈宏华, 许轶明, 等. 肌少症的诊断与治疗研究进展[J]. 内科理论与实践, 2021, 16(3): 220-224. |
/
| 〈 |
|
〉 |
